The Claim
In adults with type 2 diabetes, the simultaneous elevation of two or more inflammatory biomarkers (suPAR, IL-6, or hsCRP) is associated with a 1.9- to 2.5-fold higher risk of all-cause mortality and major adverse cardiovascular events compared to the presence of one or no elevated biomarkers, independent of traditional risk factors.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Adults with type 2 diabetes who have two or more elevated inflammatory biomarkers have a 1.9- to 2.5-fold higher risk of dying from any cause or experiencing a major cardiovascular event than those with one or none elevated, regardless of other known risk factors.
See the scientific wording
In adults with type 2 diabetes, having two simultaneously elevated inflammatory biomarkers (suPAR, IL-6, or hsCRP) is associated with a 1.9- to 2.5-fold higher risk of all-cause mortality and major adverse cardiovascular events compared to those with only one or none elevated, independent of traditional risk factors.
When two or more inflammatory signals are high at the same time, they damage the inside of blood vessels, make plaques in arteries more likely to rupture, and cause the heart and blood vessels to work harder, leading to heart attacks, strokes, or death.
What the research says
1 studyIn people with type 2 diabetes, having two high inflammation markers in the blood means they’re almost twice as likely to die or have a serious heart problem over the next decade, even when doctors already account for other health problems like high blood pressure or cholesterol.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.